🔴 Moderna is trading 18% down today after profit-taking from August 19 surge

Moderna is trading at $143.77 (-17.55%) after apparent profit-taking following its August 19 surge.

• Shares surged 176.97% on August 19 to $174.38.
• The rally followed positive Phase 3 INTerpath-001 results for intismeran autogene with Merck’s KEYTRUDA, meeting recurrence-free and distant-metastasis-free survival endpoints in melanoma patients.
• Biotech sentiment remains supportive; today’s decline reflects heavy post-rally selling rather than a new negative company announcement.